Altshuler Shaham LTD Castle Biosciences Inc Transaction History

Altshuler Shaham LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $27,939 - $42,843	-558 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$58.92 - $97.33 $6,657 - $10,998	-113 Reduced 16.84%	558 $38,000
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $5,973 - $10,007	137 Added 25.66%	671 $45,000
Q3 2020 Nov 10, 2020	BUY	$38.47 - $52.03 $20,542 - $27,784	534 New	534 $27,000
Q1 2020 May 12, 2020	SELL	$23.08 - $35.53 $11,101 - $17,089	-481 Closed	0 $0

Q4 2019 Feb 11, 2020	BUY	$15.74 - $35.04 $7,570 - $16,854	481 New	481 $17,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.